Literature DB >> 833376

Lymphocyte responses to purified ragweed allergens in vitro. I. Proliferative responses in normal, newborn, agammaglobulinemic, and atopic subjects.

R H Buckley, F Seymour, S O Sanal, D R Ownby, W G Becker.   

Abstract

To evaluate cell-mediated immune responsiveness to pollen allergens in atopic subjects, we studied the deoxyribonucleic acid (DNA) synthetic responses of their cultured lymphocytes to purified ragweek antigens E, K, and Ra-3. Since lymphocytes from some highly ragweed-sensitive subjects gave poor proliferative responses when harvested on day 6, we undertook a series of dose-response and time-course studies in atopic and control subjects. Surprisingly, vigorous DNA synthetic responses to antigen E occurred with lymphocytes from all 45 subjects, including 19 highly ragweed-sensitive atopic and control subjects. Surprisingly, vigorous DNA synthetic responses to antigen E occurred with lymphocytes from all 45 subjects, including 19 highly ragweed-sensitive atop adults (8 immunotherapy treated, 11 untreated); 13 nonatopic controls; 4 newborns, and 9 agammaglobulinemic patients. The geometric mean of peak response counts per minute in all 45 subjects was 21,163 and in unstimulated cultures was 2,416 (p = less than 0.0001). The mean day on which the maximal responses occurred was 8.7, and the mean dose eliciting the maximum responses was 59 mug/ml. Statistical comparisons of the stimulated culture data revealed no significant intergroup differences. The finding of vigorous responsiveness to these purified pollen allergens by lymphocytes from nonatopic normal, newborn, and agammaglobulinemic subjects suggests that ragweed pollen antigens are either ubiquitous and lead to cell-mediated responsiveness in all subjects with intact cell-mediated inmunity, or that they may have miogenic properties in addition to their known antigenic properties.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 833376     DOI: 10.1016/0091-6749(77)90180-4

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  6 in total

1.  Lymphocyte sensitization to Aspergillus fumigatus in allergic bronchopulmonary aspergillosis.

Authors:  C A Walker; P Fitzharris; J L Longbottom; A J Taylor
Journal:  Clin Exp Immunol       Date:  1989-04       Impact factor: 4.330

2.  Allergen presentation by epidermal Langerhans' cells from patients with atopic dermatitis is mediated by IgE.

Authors:  G C Mudde; F C Van Reijsen; G J Boland; G C de Gast; P L Bruijnzeel; C A Bruijnzeel-Koomen
Journal:  Immunology       Date:  1990-03       Impact factor: 7.397

3.  T cell epitopes of the major fraction of rye grass Lolium perenne (Lol p I) defined using overlapping peptides in vitro and in vivo. I. Isoallergen clone1A.

Authors:  G A Bungy Poor Fard; Y Latchman; S Rodda; M Geysen; I Roitt; J Brostoff
Journal:  Clin Exp Immunol       Date:  1993-10       Impact factor: 4.330

4.  In vitro selective expansion of allergen specific T cells from atopic patients.

Authors:  A Lanzavecchia; P Santini; E Maggi; G F Del Prete; P Falagiani; S Romagnani; M Ferrarini
Journal:  Clin Exp Immunol       Date:  1983-04       Impact factor: 4.330

5.  MHC class II restriction specificity of cloned human T lymphocytes reactive with Dermatophagoides farinae (house dust mite).

Authors:  R E O'Hehir; D D Eckels; A J Frew; A B Kay; J R Lamb
Journal:  Immunology       Date:  1988-08       Impact factor: 7.397

6.  The effect of Dermatophagoides pteronyssinus allergens on proliferation and CD23 antigen expression of peripheral blood lymphocytes from atopic patients.

Authors:  Y J Cho; S H Oh; J D Lee; S H Cho; Y Y Kim; H B Moon
Journal:  Korean J Intern Med       Date:  1992-01       Impact factor: 2.884

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.